Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

62 trials with published results (15%)

Research Maturity

200 completed trials (49% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.6%

19 terminated out of 412 trials

Success Rate

91.3%

+4.7% vs benchmark

Late-Stage Pipeline

5%

20 trials in Phase 3/4

Results Transparency

31%

62 of 200 completed with results

Key Signals

62 with results91% success19 terminated

Data Visualizations

Phase Distribution

341Total
Not Applicable (245)
Early P 1 (3)
P 1 (22)
P 2 (51)
P 3 (11)
P 4 (9)

Trial Status

Completed200
Recruiting79
Unknown53
Terminated19
Withdrawn19
Not Yet Recruiting16

Trial Success Rate

91.3%

Benchmark: 86.6%

Based on 200 completed trials

Clinical Trials (412)

Showing 20 of 20 trials
NCT05478759Not ApplicableActive Not Recruiting

Innovative Multimodal and Attention Training to Improve Emotion Communication in Veterans With TBI and PTSD

NCT07851090RecruitingPrimary

Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel

NCT06803043Not ApplicableEnrolling By Invitation

Evaluation of a Trauma-Informed Partner Violence Intervention Program

NCT07714083Not ApplicableNot Yet RecruitingPrimary

Cognitive Processing Therapy for Posttraumatic Stress Disorder and Co-occurring Lived Experience Stress

NCT05349877Not ApplicableCompleted

Efficacy of a Brief Intervention to Improve Sexual and Gender Minorities' Mental Health: Randomized Controlled Trial.

NCT07836647Phase 3RecruitingPrimary

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD

NCT07071350Phase 2Recruiting

Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms

NCT06988787Not ApplicableRecruiting

Multifaceted Intervention to Restore Resilience and Overcome Risk

NCT07456696Phase 3RecruitingPrimary

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

NCT05943665Phase 2Completed

MDMA for AUD/PTSD Comorbidity

NCT06990191Not ApplicableRecruitingPrimary

A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD

NCT04801589Phase 3Active Not Recruiting

Goal-Directed Sedation in Mechanically Ventilated Infants and Children

NCT05541406Not ApplicableRecruiting

Efficacy of a Multi-level School Intervention for LGBTQ Youth

NCT06957067Not ApplicableRecruitingPrimary

Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course

NCT07670702Phase 3Enrolling By InvitationPrimary

An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD

NCT06371404Recruiting

Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat

NCT07351305Not ApplicableRecruiting

Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI

NCT06222268Phase 1Not Yet Recruiting

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery

NCT03932773Not ApplicableRecruitingPrimary

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

NCT05790239Phase 2RecruitingPrimary

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Scroll to load more

Research Network

Activity Timeline